Document Sample
Letterhead Powered By Docstoc
					     “Beyond Hearing Aids: Implantable Hearing Technology”

       Date:          January 29, 2008

       Time:          5:30-8:30 pm

       Location:      Cohen Rosenburg Building, Mel Cohen Conference

       Address:       1919 E Thomas Rd, Phoenix, AZ 85016

Sponsored by Cochlear Americas

Over 100,000 people have received a Nucleus cochlear implant or Baha ® device. While
each experience is unique, the desire for unlimited opportunities and access to a fuller,
richer world of sound is the same. Yet, there are many more who could benefit from
this amazing technology.
If you are a hearing healthcare professional and work with adults or children who no
longer benefit from hearing aids, you will want to attend this event. This seminar will
assist professionals in identifying patients who may benefit from a Nucleus cochlear
implant or Baha system. Help people you know to take the first step of an exciting

If you work with patients who cannot benefit from hearing aids or no longer receive
as much benefit as they need, we welcome you to attend this free informational
forum to learn more about two remarkable alternative treatment options. This event
will highlight Cochlear’s implantable hearing technology, the Nucleus ® Freedom™
cochlear implant system and the Baha ® direct bone conduction system. Areas of
discussion will include candidacy, the evaluation process, and patient outcomes. We
will also discuss the need for establishing and building relationships between implant
centers and referring hearing healthcare professionals and the benefits of providing
binaural hearing by maintaining a hearing aid on the non-implant ear or through
bilateral implantation.

Implant candidacy and patient outcomes have changed dramatically over the past few
years. Cochlear’s Nucleus Freedom cochlear implant system is approved by the FDA
for people with severe-to-profound hearing and is designed to mimic natural hearing.
Cochlear’s Baha system is the only implantable treatment for hearing loss that works
through direct bone conduction and offers an effective treatment for many wi th mixed
and conductive hearing loss or Single Sided Deafness (SSD™). Cochlear’s
implantable hearing technology continues to advance and change the lives of
those who use it. Join us to find out how these innovations can help your patients
discover the world of sound they have been missing.

Refreshments will be served

           Overview of Hearing and Hearing Loss
           Overview of Cochlear’s Implant Systems (Nucleus Freedom and Baha)
           Candidacy Criteria — Nucleus and Baha
           Post-operative, Follow-up, Process and Outcomes
           Pediatric Considerations
           Benefits of Binaural and Bimodal Hearing
           Building Successful Partnerships — Referring Hearing Professionals and
           Implant Centers
           Implant Users Share Their Stories


We are pleased to offer these informational forums at no charge, however advance
registration is required due to limited seating. Feel free to extend this invitation to your
colleagues. The registration deadline is January 22, 2008.

To register, please go to www.regonline.com/172219

For registration questions, call Stacy Long, 800 523 5798 ext 124

Cochlear Americas is pending approval by the American Academy of Audiology to offer AAA CEUs for
this activity. The program would be worth a maximum of .3 CEUs. Academy approval of this continuing
education activity does not imply endorsement of course content, specific products, or clinical procedures.

Cochlear Americas is approved by the Continuing Education Board of the American Speech-
Language-Hearing Association (ASHA) to provide continuing education activities in speech-
language pathology and audiology. This program is offered for .3 CEUs (intermediate level;
professional area). ASHA CE Provider approval does not imply endorsement of course content,
specific products, or clinical procedures.

IIHIS Cochlear Americas is pending approval by the International Hearing Society for this course
to offer 2 credit hours. Approval does not imply endorsement of products or procedures.

Cochlear Company Confidentialc:\docstoc\working\pdf\3af2c601-7305-4e30-a57b-8ad0f57b4bad.doc                  Page 2 of 2